Ablevia biotech GmbH

Ablevia biotech GmbH is a biotechnology startup based in Austria, founded in 2018. The company's slogan, "selective removal of harmful antibodies," reflects its focus on developing therapeutics for the selective removal of antibodies. As of now, there is no publicly available information regarding the last investment or the investors involved with Ablevia biotech GmbH. This Austrian biotech startup has been making strides in the field of selective antibody removal, offering promising solutions for various medical conditions. With its innovative approach, Ablevia biotech GmbH has positioned itself as a potential player in the biotechnology sector. As the company continues to develop its antibody removal therapeutics, it may attract the attention of investors looking to support cutting-edge advancements in the healthcare industry. Keep an eye on Ablevia biotech GmbH as it navigates the biotech landscape with its distinctive focus on selective antibody removal.